Aryl-substituted tricyclic sulfonamides as methionyl aminopeptidase 2 modulators
US9187494B2 · kind B2 · utility
5Cited by
45References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2012 |
| Grant date | Nov 17, 2015 |
| Priority date | — |
| Expiry date | May 7, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides tricyclic sulfonamide compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2. For example, the invention relates in part to tricyclic sulfonamide compounds represented by Formula I:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.